LY3023703

LY3023703 · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for LY3023703, covering 2017-12-14 to 2018-12-14. Get the full timeline:

Most recent: Clinical Trial Update: A Multiple Dose Study of LY3023703 in Healthy Participants [Phase 1]